So, last week was less bad, and so looked good. This week on the other hand, looked really bad. Both for the market generally, and Biotechs in particular. Not uniformly, of course. Thirteen of the stock picks managed a positive performance for the week amidst a general blood bath. The best overall YTD stock, OPTN managed to eke out a position in the top 5 for the week, at +4.8%. But the net result for the portfolios was a 11 % haircut for the week, with the median YTD performance of -18.6%. Not a single portfolio is in the black, either for the week or for YTD. But the group should take some comfort in that the are able to say that they are at least outperforming the S&P 500 Biotech stock index, YTD -19.6. Four portfolios are even doing better than a NASDAQ index fun.
The phrase “sucking wind” springs to mind.
On the other hand, with any luck, these companies are coming up with new ideas to cure or mitigate disease.
|
Report Time Ranges
|
|
|
From
|
To
|
Recent
|
1/14/2022
|
1/21/22
|
YTD
|
12/31/21
|
Index Performance
|
|
Symbol
|
Recent
|
YTD
|
|
^IXIC
|
-7.55%
|
-11.99%
|
^NBI
|
-7.42%
|
-14.04%
|
^SPSIBI
|
-10.57%
|
-19.63%
|
Share Performance
|
Recent
|
YTD
|
Top 5
|
Bottom 5
|
Top 5
|
Bottom 5
|
BBI
|
11.965%
|
CRDF
|
-46.137%
|
OPTN
|
35.19%
|
PACB
|
-50.88%
|
4BB.L
|
7.479%
|
PTE
|
-27.434%
|
NCNA
|
15.97%
|
NBSE
|
-44.84%
|
IDIA.SW
|
6.699%
|
ARCT
|
-26.553%
|
MACK
|
15.86%
|
JSPR
|
-44.20%
|
DRMA
|
5.806%
|
NBSE
|
-26.014%
|
IDIA.SW
|
14.85%
|
DYN
|
-39.36%
|
OPTN
|
4.785%
|
LPTX
|
-25.704%
|
LQDA
|
12.94%
|
CRDF
|
-38.52%
|
Top 10 Portfolio Performance YTD
|
|
RKRW
|
-9.35%
|
|
HORSEINALFALFA
|
-9.50%
|
DEW DILIGENCE
|
-9.75%
|
DIEGOSAN
|
-12.04%
|
TOMATO
|
-12.54%
|
GENEGURU
|
-12.73%
|
TECHNETIUM
|
-12.86%
|
BIOSCIENTISTSA
|
-13.01%
|
JFM WINTER
|
-13.32%
|
ARTHUR RADLEY
|
-14.35%
|
Average and Median Portfolio Performance
|
|
Avg Recent
|
Avg YTD
|
Median Recent
|
Median YTD
|
|
-$10,157
|
-18.03%
|
KMASTRA
|
-$10,003
|
MOPGCW
|
-18.59%
|
-11.04%
|
TWOONE1
|
-11.006%
|
|
